Insiders Opthea Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:04 2024-05-21 EDT			5-day change	1st Jan Change
0.64 ^AUD	-0.78%		-5.19%	+12.28%

04-03	Opthea Limited Announces Board Changes	CI
02-29	Opthea Posts H1 FY24 Loss per Share of $0.1623; R&D Expenses Jump	MT

Opthea Limited Announces Board Changes	04-03	CI
Opthea Appoints Chief Medical Advisor; Shares Decline 4%	02-19	MT
Opthea Appoints Arshad M. Khanani as Chief Medical Advisor	02-19	CI
Opthea Makes Management Appointments As Part of Next Stage Drug Trial; Shares Up 13%	02-01	MT
Opthea Strengthens Team with Key Clinical and Regulatory Hires	02-01	CI
Opthea Limited Appoints Peter Lang as Chief Financial Officer	23-10-26	CI
Opthea Limited Announces Transition of Megan Baldwin to Founder and Chief Innovation Officer, Effective October 27, 2023	23-10-26	CI
Opthea Limited Announces Executive Changes	23-10-26	CI
Opthea Selects Name for Eye Medication Candidate	23-07-26	MT
Opthea Limited Announces ?Sozinibercept? as the Nonproprietary Drug Name for OPT-302	23-07-26	CI
Opthea Appoints Senior Medical Adviser	23-07-11	MT
Opthea's Chief Medical Officer Joel Naor Resigns	23-07-10	MT
Opthea Limited Announces Executive Changes	23-07-10	CI
Opthea Limited Appoints Anshul Thakral as Non-Executive Director of the Board	23-06-08	CI
Opthea Appoints CFO	22-10-24	MT
Opthea Appoints Timothy Morris as CFO	22-10-24	MT
Opthea Limited Appoints Timothy E. Morris as Chief Financial Officer	22-10-24	CI
Imugene Appoints CFO	22-07-18	MT
Opthea Limited Announces Board Appointments	22-04-20	CI
Opthea Names New Chief Medical Officer; Shares Decline 7%	22-03-02	MT

No results for this search